Viridis BioPharma Pvt. Ltd. is a leading techno-marketing organization based in Mumbai, India offering innovative ingredients and solutions to the pharmaceutical, nutraceutical and cosmeceutical/dermatology Industry. Viridis group has been associated with Unigen for nearly a decade with regard to the promotion and distribution of various botanically derived nutraceuticals in the Indian market from the Unigen portfolio. This has been a successful cooperation with both parties having a deep understanding of science, research and technology. The association has also expanded to bringing a range of innovative cosmeceutical ingredients from the Unigen Beauty portfolio to meet the growing needs of the Indian personal care and cosmetic market. These ingredients offer innovative solutions to address a wide range of applications in skin and hair care.
“Bakutrol® was selected as the key ingredient in this innovative offering because of its unique benefit of not only reducing acne lesions but also addressing post inflammatory hyperpigmentation, which is a major concern in individuals affected by acne related skin issues.”
Ashit Vora, Managing Director of Viridis BioPharma mentions that, “The Viridis group is pleased to associate with Unigen to promote, market and distribute their range of innovative, science driven active ingredients to the dermatology and personal care industry in India. The Indian derma and cosmeceutical industry is going through paradigm shifts with consumers becoming more educated and demanding on the quality and efficacy of their skin-care needs and products. Unigen’s botanically derived, science driven skin-care active ingredients, offer safe and efficacious solutions backed by extensive studies.
Viridis is excited to announce the launch of Healthyr-U Anti-Acne and Hyperpigmentation cream in India by leading healthcare provider Zuventus Healthcare Ltd. Healthyr-U Anti-Acne and Hyperpigmentation cream is an innovative solution in this large market segment, based on the key ingredient Bakutrol® from Unigen, Inc. Bakutrol® was selected as the key ingredient in this innovative offering because of its unique benefit of not only reducing acne lesions but also addressing post inflammatory hyperpigmentation, which is a major concern in individuals affected by acne related skin issues.”
“Healthyr-U, a Wellness initiative of Zuventus Healthcare Ltd., is elated to launch clinically validated Bakutrol®, which provides a 360 degree advanced approach to Acne and Hyper pigmentation. It thus addresses the Indian consumer’s dilemma, who did not have a choice, other than using currently available partially acting products” – Mr. Shriram Balasubramanian, Director Business Development and Commercial, Zuventus Healthcare Ltd.
Congratulations to Zuventus Healthcare on this product with a great fit for the Indian beauty marketplace!